Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-023838
Filing Date
2022-02-15
Accepted
2022-02-15 16:48:04
Documents
1
Period of Report
2022-02-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm226876-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm226876-1_4seq1.xml 4 3425
  Complete submission text file 0001104659-22-023838.txt   4921
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001
Business Address
Cawkwell Gail (Reporting) CIK: 0001761167 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 22639846